A dedicated team of Russian scientists and medical experts from the institutions that form part of the World-Class Research Centre (Almazov Centre and the Institute of Experimental Medicine) created the scientific journal – Russian Journal of Personalized Medicine.
The journal focuses on prominent topics of medicine such as genetic risks and causes of diseases, epigenetics, biomarkers of disease and health, microbiota and antimicrobial therapy, targeted therapy, pharmacogenetics and pharmacogenomics, gene therapy and genome editing technologies, artificial intelligence and machine learning as a tool for personalized medicine.
The journal aims to help scientists timely share their research results with the professional community and present the updates on current research and developments.
Evgeny Shlyakhto, Director General of Almazov National Medical Research Centre, Academician of the Russian Academy of Science, Honoured Scientist of Russia, President of the Russian Society of Cardiology, chief visiting cardiologist of the Russian Ministry of Health for the Volga, Southern, North Caucasian and Northwestern federal districts, chief visiting cardiologist of St. Petersburg Health Committee.
Maria Pospelova, MD, DSc, Leading Researcher, Head of the Group for Personalized Treatment of Postmastectomy Syndrome, associate professor at the Department of Neurology and Psychiatry, Almazov Centre.
To submit a paper, please email your inquiry to firstname.lastname@example.org.
The journal accepts only original research papers that have not been published before, are in the scope of journal and have scientific significance. We ask authors to submit the manuscript in doc/docx format, use double line spacing, font Times New Roman in size 14, include line and page numbering, all margins should be at least 20 mm. Recommended length of the manuscript: 10-20 pages for an original research or review, 4-5 pages for clinical cases, brief reports.
The following documents are required as attachments:
- Cover letter from the organization containing a brief description of the research and its relevance, explanation of its novelty, article type (topical review, case study, original research, brief report, etc.)
- Conflict of interest signed by all co-authors. Statement if the manuscript is the part of PhD thesis, if so the supervisor should sign it on the first page.
- List of three (or more) potential peer reviewers for your manuscript, including title, full name, email. These should be experts in their field of study, who will be able to provide an objective assessment of the manuscript. Any suggested peer reviewers should not have published with any of the authors of the manuscript within the past 5 years and should not be members of the same research group. If applicable, excluded reviewers could be mentioned.
Manuscript should contain the following sections:
- Key words
- Body text
- Acknowledgements (if any)
- Conflict of interest
- Figure legends
- Title page
The title should be in capital letters, boldface type. To index authors, use last name and initials. Entire information about all authors should be provided below (full name, titles, affiliations, city, country, email, phone).
The title page should be in Russian and English.
This section should specify the corresponding author.
- Abstract/Key words
The abstract should be in Russian and English. For an original research paper, it should be structured and contain the following sections: Background, Objective, Design and methods, Results, Conclusion. For reviews or brief reports, it can be unstructured and contain a description of no longer than 200 words and at least 6 key words.
- Body text containing the following sections:
- List of abbreviations
It includes all abbreviations used more than three times.
- Body text
It should be structured: Background, Design and methods, Results, Discussion and Conclusion. Use SI units, please ensure all special characters are embedded in the text.
- Acknowledgments (if any)
Authors should follow Vancouver citation style. Unpublished results and personal communications are not recommended in the reference list. References should be numbered according to the order of appearance in the text and with usage of square brackets in the text:  or [1, 2]. Every reference cited in the text should be present in the reference list and vice versa. If there are more than three authors, include only three names followed by et al.
When citing a source that has more than two authors, cite only the last name of the first-listed author, followed by et al. For example: Smith AA, et al. (2008).
Sample references are given below:
Article citation (original language – English):
Smith A, Jones B, Clements S. Clinical transplantation of tissue-engineered airway. Lancet. 2008; 372:1201–1209.
Article citation (original language – Russian):
Bart BYa, Larina VN, Brodskyi MS. Cardiac remodeling and clinical prognosis in patient with chronic heart failure and complete left bundle branch block. Russ J Cardiol. 2011; 6: 4–8. In Russian [Барт Б. Я., Ларина В. Н., Бродский М. С. Ремоделирование сердца и прогноз больных с хронической сердечной недостаточностью при наличии полной блокады левой ножки пучка Гиса. Российский кардиологический журнал. 2011; 6:4–8].
Book citation (original language – Russian):
Shlyakhto EV, Konradi AO, Tsyrlin VA. The autonomic nervous system and hypertension. SPb.: Meditsinskoe izdatel'stvo, 2008. р. 200. In Russian [Шляхто Е. В., Конради А. О., Цырлин В. А. Вегетативная нервная система и артериальная гипертензия. СПб.: Медицинское издательство, 2008. c. 200].
Chapter citation (original language – English):
Nichols WW, O'Rourke MF. Aging, high blood pressure and disease in humans. In: Arnold E, ed. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 3rd ed. London/Melbourne/Auckland: Lea and Febiger, 1990:398–420.
Chapter citation (original language – Russian):
Diagnostics and treatment of chronic heart failure. In. National clinical guidelines 4th ed. Moscow: Silicea-Poligraf, 2011: 203–296. In Russian [Диагностика и лечение хронической сердечной недостаточности. В кн: Национальные клинические рекомендации. 4 е издание. М.: Силицея-Полиграф, 2011: 203–296].
Web link citation:
Panteghini M. Recommendations on use of biochemical markers in acute coronary syndrome: IFCC proposals. eJIFCC 14. http://www.ifcc.org/ejifcc/vol14no2/1402062003014n.htm (28 May 2004)
Patent citation (original language – Russian):
Tatarinov AA, Treshkur TV. A method for predicting the effectiveness of myocardial revascularization in patients with coronary heart disease with ventricular high grade arrhythmias. Patent on the application #2012105193, 27.11.2012. In Russian [Татаринова А. А., Трешкур Т. В. Способ прогнозирова- ния эффективности операции реваскуляризации миокарда у больных ишемической болезнью сердца с желудочковыми аритмиями высоких градаций. Патент по заявке No 2012105193 от 27.11.2012 г].
Conference abstract citation (original language – English)
Geirsson A, Singh M, Ali R et al. Modulation of transforming growth factor-β signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers. Circulation. 2012;126 (11 Suppl 1): S189–197
Figure, graph and table legends should be concise and data included in them should comply with those mentioned in the main text.
The number of the referred figure or table should be inserted into the text between round brackets, e.g. (Figure 1), (Table 1).
- Figures, graphs and tables
Figures, graphs, and tables should be provided as separate files, not embedded in the manuscript file. Each figure (jpeg), graph (tiff) and table (doc/docx) should be submitted as a separate file and numbered according to its occurrence in the text of manuscript. Individual figure file should be in optimal size (resolution at least 300 dpi). All images must be clear and legible. Lines, symbols, and letters must be sharp, smooth, and complete.
We encourage submitting of black and white images always when it is possible.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal the right of first publication simultaneously licensed under a Creative Commons Attribution License that allows others to share the paper with an acknowledgement of the authorship and initial publication in this journal.
- Authors reserve the right to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the paper (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their paper online (e.g., in institutional repositories or on their personal website) prior to and during the submission process, as it can lead to productive exchanges as well as earlier and greater citation of published work (see The Effect of Open Access).
Names and emails entered on the website of this journal will be used solely for the purposes indicated by the journal and will not be used for any other purpose or shared with other individuals and organizations.